Key result
Montanide ISA 206 VG adjuvant induced a significantly higher and more durable neutralizing antibody response against FMDV in goats compared to aluminum hydroxide at 9 months (mean difference 1.89, p<0.001).
Why the study?
Inactivated foot-and-mouth disease vaccines require adjuvants for a durable response, but many manufacturers still use alum rather than mineral oil-based adjuvants like Montanide ISA 206 VG.
Does Montanide ISA 206 VG adjuvant improve neutralizing antibody response compared to aluminum hydroxide adjuvant in goats vaccinated against FMDV?
RCT (n=6)
randomly divided
No
Does Montanide ISA 206 VG adjuvant improve neutralizing antibody response compared to aluminum hydroxide adjuvant in goats vaccinated against FMDV?
Mean Difference: 1.89
p-value: p=<0.001
Montanide ISA 206 VG adjuvant induces a higher and more durable neutralizing antibody response against FMDV in goats compared to aluminum hydroxide.
Foot-and-mouth disease (FMD) has a high prevalence in cloven-hoofed animals. It is also highly contagious and remains a serious threat to livestock worldwide. Despite the widespread vaccination program in Iran, outbreaks of FMD continue to occur. Vaccination is one of the most effective methods of preventing FMD. The vaccines used in Iran are of the inactivated type and contain several serotypes. Since inactivated vaccines without adjuvants do not induce a high and durable antibody response, it is necessary to use adjuvants. Montanide ISA 206 VG is a mineral oil-based adjuvant that produces a water-in-oil-in-water (w:o:w) emulsion in vaccine preparations. However, a large number of manufacturers in Iran and around the world still use alum adjuvant (with or without saponin) to produce the FMD vaccine. This study used Montanide ISA 206 and alum adjuvants to administer the O2010 serotype of the FMD virus to goats. A total of six goats were divided randomly into three groups. Vaccines were administered subcutaneously twice, at a one-month interval. Blood sampling was done at different times, and the micro-neutralization method was used to measure the neutralizing antibody titer in each serum. Seven days after the second vaccination, the alum group's antibody titer was higher but not statistically significant. However, from the 28th day after the second injection until the end of the study, the Montanide ISA 206 group's antibody titer was significantly higher than that of the alum group. Six months after the second injection, the antibody titer in the ISA 206 group remained at the peak level, while in the alum group, it decreased and reached the minimum protective level. Nine months after the second injection, the antibody titer remained at its peak level in the ISA 206 group, whereas it dropped significantly in the alum group. Based on the findings, ISA 206 VG is capable of generating long-term humoral immunity in goats against the FMD serotype O2010 and could replace aluminum hydroxide adjuvants in FMD vaccine preparations.
No takes yet. Share an insight, caveat, or question.
Taghizadeh et al. (2023) conducted an RCT in Foot-and-mouth disease (FMD) (n=6). Montanide ISA 206 VG adjuvant vs. Aluminum hydroxide adjuvant was evaluated on Neutralizing antibody titer at 9 months after second vaccination (Mean difference 1.89, p=<0.001). Montanide ISA 206 VG adjuvant induced a significantly higher and more durable neutralizing antibody response against FMDV in goats compared to aluminum hydroxide at 9 months (mean difference 1.89, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: